| scholarly article | Q13442814 |
| P356 | DOI | 10.1086/599039 |
| P698 | PubMed publication ID | 19441981 |
| P50 | author | Michael A. Pfaller | Q62070176 |
| William J Steinbach | Q89583459 | ||
| Kieren A Marr | Q90630865 | ||
| P2093 | author name string | Jay A Fishman | |
| Elias J Anaissie | |||
| Dionissios Neofytos | |||
| David L Horn | |||
| Ali J Olyaei | |||
| Chi-Hsing Chang | |||
| Karen M Webster | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| epidemiology | Q133805 | ||
| candidemia | Q54946225 | ||
| P304 | page(s) | 1695-1703 | |
| P577 | publication date | 2009-06-01 | |
| P1433 | published in | Clinical Infectious Diseases | Q5133764 |
| P1476 | title | Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry | |
| P478 | volume | 48 |
| Q92688020 | "Candida Albicans Interactions With The Host: Crossing The Intestinal Epithelial Barrier" |
| Q40306211 | A Risk Score for Fluconazole Failure among Patients with Candidemia |
| Q33736871 | A case of Candida glabrata severe urinary sepsis successfully treated with micafungin |
| Q36305684 | A combination approach to treating fungal infections |
| Q90352817 | A multicenter retrospective analysis of the antifungal susceptibility patterns of Candida species and the predictive factors of mortality in South Korean patients with candidemia |
| Q42216247 | A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality. |
| Q34041471 | A novel flucytosine-resistant yeast species, Candida pseudoaaseri, causes disease in a cancer patient |
| Q64117762 | A prospective, multi-center study of Candida bloodstream infections in Chile |
| Q64256804 | A rare primary Candida parapsilosis infection of the knee joint in a patient without predisposing factors: A case report |
| Q33851387 | A real time PCR assay on blood for diagnosis of invasive candidiasis in immunocompromised patient |
| Q35745515 | Abolishing Cell Wall Glycosylphosphatidylinositol-Anchored Proteins in Candida albicans Enhances Recognition by Host Dectin-1. |
| Q36362975 | Accurate and rapid identification of Candida spp. frequently associated with fungemia by using PCR and the microarray-based Prove-it Sepsis assay |
| Q42113240 | Accurate identification of Candida parapsilosis (sensu lato) by use of mitochondrial DNA and real-time PCR. |
| Q38400673 | Acid suppressing therapy as a risk factor for Candida esophagitis |
| Q41706308 | Adherence to clinical practice guidelines for the treatment of candidemia at a Veterans Affairs Medical Center |
| Q26995458 | Advances in targeting the vacuolar proton-translocating ATPase (V-ATPase) for anti-fungal therapy |
| Q35046598 | Age-associated alteration in naive and memory Th17 cell response in humans |
| Q36521347 | Agreement of Direct Antifungal Susceptibility Testing from Positive Blood Culture Bottles with the Conventional Method for Candida Species |
| Q34036214 | Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome |
| Q45798043 | Anti-Candida activity of antimicrobial impregnated central venous catheters |
| Q35941512 | Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection |
| Q38865776 | Antifungal Immunological Defenses in Newborns. |
| Q46666432 | Antifungal activities of diphenyl diselenide alone and in combination with fluconazole or amphotericin B against Candida glabrata |
| Q38997402 | Antifungal activity of extracts and isolated compounds from Buchenavia tomentosa on Candida albicans and non-albicans. |
| Q60917877 | Antifungal activity of well-defined chito-oligosaccharide preparations against medically relevant yeasts |
| Q46899765 | Antifungal catheter lock therapy for the management of a persistent Candida albicans bloodstream infection in an adult receiving hemodialysis |
| Q37993110 | Antifungal chemoprophylaxis in children and adolescents with haematological malignancies and following allogeneic haematopoietic stem cell transplantation: review of the literature and options for clinical practice |
| Q28489096 | Antifungal efficacy during Candida krusei infection in non-conventional models correlates with the yeast in vitro susceptibility profile |
| Q37727168 | Antifungal prophylaxis and treatment in patients with hematological malignancies |
| Q40542769 | Antifungal susceptibility of Candida species isolated from patients with candidemia in southern Taiwan, 2007-2012: impact of new antifungal breakpoints |
| Q33903375 | Antifungal susceptibility of invasive yeast isolates in Italy: the GISIA3 study in critically ill patients |
| Q45988034 | Antifungal use influences Candida species distribution and susceptibility in the intensive care unit. |
| Q64989502 | Are In Vitro Susceptibilities to Azole Antifungals Predictive of Clinical Outcome in the Treatment of Candidemia? |
| Q38111859 | Aspartic proteinases of Candida spp.: role in pathogenicity and antifungal resistance. |
| Q36633724 | Assessment of candidemia-attributable mortality in critically ill patients using propensity score matching analysis |
| Q100512296 | Automated quantification of Candida albicans biofilm-related phenotypes reveals additive contributions to biofilm production |
| Q21194915 | Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unit |
| Q58806129 | Biguanides enhance antifungal activity against Candida glabrata |
| Q41527683 | Bimodal Influence of Vitamin D in Host Response to Systemic Candida Infection-Vitamin D Dose Matters |
| Q64099066 | Bioactive 2-(Methyldithio)Pyridine-3-Carbonitrile from Persian Shallot ( Regel.) Exerts Broad-Spectrum Antimicrobial Activity |
| Q31151975 | Bloodstream infections by Malassezia and Candida species in critical care patients |
| Q38694666 | Bloodstream infections in internal medicine. |
| Q38741813 | Breakthrough candidemia in children: clinical and microbiological characteristics, therapeutic strategies and impact on outcomes |
| Q40451792 | Burden of fungal infections in Qatar. |
| Q37384004 | CX3CR1-dependent renal macrophage survival promotes Candida control and host survival |
| Q28484616 | Calcium-activated-calcineurin reduces the In vitro and In vivo sensitivity of fluconazole to Candida albicans via Rta2p |
| Q39805256 | Candida Arthritis after Arthroscopic Arthroplasty in a Patient without Predisposing Factors |
| Q92592097 | Candida Bloodstream Infection: Changing Pattern of Occurrence and Antifungal Susceptibility over 10 Years in a Tertiary Care Saudi Hospital |
| Q39222757 | Candida albicans Is Resistant to Polyglutamine Aggregation and Toxicity |
| Q36053516 | Candida albicans Quorum Sensing Molecules Stimulate Mouse Macrophage Migration |
| Q91700921 | Candida albicans Ras1 Inactivation Increases Resistance to Phagosomal Killing by Human Neutrophils |
| Q46876396 | Candida albicans and non-Candida albicans fungemia in an institutional hospital during a decade |
| Q35128623 | Candida albicans morphology and dendritic cell subsets determine T helper cell differentiation |
| Q34539797 | Candida and host determinants of susceptibility to invasive candidiasis |
| Q41700910 | Candida and other yeasts of clinical importance in Aseer region, southern Saudi Arabia. Presentation of isolates from the routine laboratory setting |
| Q35193171 | Candida colonization as a risk marker for invasive candidiasis in mixed medical-surgical intensive care units: development and evaluation of a simple, standard protocol |
| Q38190962 | Candida dubliniensis spondylodiscitis in an immunocompetent patient. Case report and review of the literature |
| Q34187320 | Candida dubliniensis: an appraisal of its clinical significance as a bloodstream pathogen |
| Q34666621 | Candida glabrata perinephric abscess |
| Q38553440 | Candida glabrata--unique features and challenges in the clinical management of invasive infections |
| Q38214878 | Candida glabrata: a deadly companion? |
| Q45350702 | Candida glabrata: an emerging pathogen in Brazilian tertiary care hospitals |
| Q33825621 | Candida infections of the genitourinary tract |
| Q37450019 | Candida parapsilosis and Candida guillermondii: emerging pathogens in nail candidiasis |
| Q61797903 | Candida sp. Infections in Patients with Diabetes Mellitus |
| Q92156552 | Candida spp./Bacteria Mixed Biofilms |
| Q40318343 | Candida tropicalis Biofilms: Biomass, Metabolic Activity and Secreted Aspartyl Proteinase Production. |
| Q40045020 | Candida vertebral osteomyelitis (CVO) 28 cases from a 10-year retrospective study in France |
| Q42375493 | Candidaemia in a tertiary hospital in Nigeria |
| Q38233262 | Candidaemia observed at a university hospital in Milan (northern Italy) and review of published studies from 2010 to 2014. |
| Q40051828 | Candidemia in the Neonatal Intensive Care Unit: A Retrospective, Observational Survey and Analysis of Literature Data. |
| Q41742158 | Candidemia in the intensive care unit: analysis of direct treatment costs and clinical outcome in patients treated with echinocandins or fluconazole. |
| Q36901716 | Candidiasis in Pediatrics; Identification and In vitro Antifungal Susceptibility of the Clinical Isolates |
| Q57579555 | Candidoses oropharyngées (COP) et cancers solides |
| Q37442782 | Candiduria in haematologic malignancy patients without a urinary catheter: nothing more than a frailty marker? |
| Q50021448 | Caspofungin resistant disseminated candidiasis in a 7-year-old girl with T cell lymphoma: a case report |
| Q33826372 | Caspofungin use in patients with invasive candidiasis caused by common non-albicans Candida species: review of the caspofungin database |
| Q30837287 | Cell Intrinsic Galectin-3 Attenuates Neutrophil ROS-Dependent Killing of Candida by Modulating CR3 Downstream Syk Activation |
| Q51792973 | Central venous access in oncology: ESMO Clinical Practice Guidelines. |
| Q41711370 | Cervical Bone Graft Candida albicans Osteomyelitis: Management Strategies for an Uncommon Infection |
| Q47749844 | Changes in the epidemiological landscape of invasive candidiasis. |
| Q43984760 | Changing epidemiology of human mycoses--China and beyond |
| Q34505582 | Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America |
| Q33683476 | Clinical and microbiological characteristics, and impact of therapeutic strategies on the outcomes of children with candidemia |
| Q30781344 | Clinical characteristics and outcomes in 303 HIV-infected patients with invasive fungal infections: data from the Prospective Antifungal Therapy Alliance registry, a multicenter, observational study |
| Q35598171 | Clinical performance of the (1,3)-β-D-glucan assay in early diagnosis of nosocomial Candida bloodstream infections |
| Q35136379 | Clinical practice patterns in hospitalized patients at risk for invasive candidiasis: role of antifungal stewardship programs in an era of rapid diagnostics |
| Q35733334 | Commensal enteric bacteria lipopolysaccharide impairs host defense against disseminated Candida albicans fungal infection |
| Q35948319 | Community acquired fungemia caused by Candida pulcherrima: diagnostic contribution of MALDI-TOF mass spectrometry |
| Q40672124 | Comparative Evaluation of the BD Phoenix Yeast ID Panel and Remel RapID Yeast Plus System for Yeast Identification |
| Q40587047 | Comparative effectiveness of echinocandins versus fluconazole therapy for the treatment of adult candidaemia due to Candida parapsilosis: a retrospective observational cohort study of the Mycoses Study Group (MSG-12). |
| Q34916656 | Comparative evaluation of a new commercial colorimetric microdilution assay (SensiQuattro Candida EU) with MIC test strip and EUCAST broth microdilution methods for susceptibility testing of invasive Candida isolates |
| Q37263608 | Comparative evolution of morphological regulatory functions in Candida species |
| Q34026915 | Comparison of albicans vs. non-albicans candidemia in French intensive care units |
| Q54943425 | Comparison of the incidence, clinical features and outcomes of invasive candidiasis in children and neonates. |
| Q42129565 | Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform |
| Q49953666 | Creation and Assessment of a Clinical Predictive Calculator and Mortality Associated With Candida krusei Bloodstream Infections. |
| Q37873554 | Current issues in the clinical management of invasive candida infections--the AGIHO, DMykG, ÖGMM and PEG web-based survey and expert consensus conference 2009. |
| Q38531765 | Current recommendations and importance of antifungal stewardship for the management of invasive candidiasis |
| Q42597625 | Declining incidence of candidemia in a tertiary inpatient pediatric population |
| Q37359653 | Deletion of the HAMP domains from the histidine kinase CaNik1p of Candida albicans or treatment with fungicides activates the MAP kinase Hog1p in S. cerevisiae transformants |
| Q36647246 | Deletion of vacuolar proton-translocating ATPase V(o)a isoforms clarifies the role of vacuolar pH as a determinant of virulence-associated traits in Candida albicans |
| Q93085271 | Determination of Pharmacodynamic Target Exposures for Rezafungin against Candida tropicalis and Candida dubliniensis in the Neutropenic Mouse Disseminated Candidiasis Model |
| Q91693316 | Development of High-Level Echinocandin Resistance in a Patient With Recurrent Candida auris Candidemia Secondary to Chronic Candiduria |
| Q35066753 | Development of echinocandin resistance in Clavispora lusitaniae during caspofungin treatment |
| Q35574038 | Diagnosis of invasive candidiasis in the ICU. |
| Q27026115 | Diagnostic challenges and opportunities in older adults with infectious diseases |
| Q44517577 | Early cryptococcal meningitis following treatment with rituximab, fludarabine and cyclophosphamide in a patient with chronic lymphocytic leukemia |
| Q37785541 | Early treatment of candidemia in adults: a review |
| Q35140020 | Echinocandin susceptibility testing of Candida isolates collected during a 1-year period in Sweden. |
| Q41939680 | Echinocandin susceptibility testing of Candida species: comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, disk diffusion, and agar dilution methods with RPMI and isosensitest media |
| Q42706331 | Echinocandin susceptibility testing of Candida spp. Using EUCAST EDef 7.1 and CLSI M27-A3 standard procedures: analysis of the influence of bovine serum albumin supplementation, storage time, and drug lots. |
| Q56794081 | Echinocandins Compared to Fluconazole for Candidemia of a Urinary Tract Source: A Propensity Score Analysis |
| Q35025431 | Effect of statin use on outcomes of adults with candidemia |
| Q44400875 | Effects of anidulafungin and voriconazole, singly and in combination, on cytokine/chemokine production by human monocyte-derived macrophages infected with Candida glabrata or activated by lipopolysaccharide |
| Q51168822 | Efficacy of micafungin in invasive candidiasis caused by common Candida species with special emphasis on non-albicans Candida species. |
| Q37832837 | Emerging opportunistic yeast infections |
| Q64272093 | Epidemiology and Outcomes of Candidemia in a Referral Center in Tehran |
| Q35959495 | Epidemiology and antifungal resistance in invasive candidiasis |
| Q41987503 | Epidemiology and antifungal susceptibility of candidemia isolates of non-albicans Candida species from cancer patients |
| Q42210762 | Epidemiology and outcome of nosocomial candidemia in elderly patients admitted prevalently in medical wards |
| Q38558193 | Epidemiology and risk factors for nosocomial Non-Candida albicans candidemia in adult patients at a tertiary care hospital in North China |
| Q35089772 | Epidemiology and treatment approaches in management of invasive fungal infections |
| Q46098829 | Epidemiology of Candida blood stream infections in patients with hematological malignancies or solid tumors |
| Q40757551 | Epidemiology of candidaemia in a tertiary care university hospital: 10-year experience with 381 candidaemia episodes between 2001 and 2010. |
| Q34635088 | Epidemiology of candidemia in Latin America: a laboratory-based survey |
| Q35071660 | Epidemiology of candidemia in Qatar, the Middle East: performance of MALDI-TOF MS for the identification of Candida species, species distribution, outcome, and susceptibility pattern. |
| Q45850889 | Epidemiology of candidemia in patients with hematologic malignancies and solid tumours in Brazil. |
| Q42943910 | Epidemiology of fungaemia in a paediatric hospital of high complexity |
| Q49587328 | Epidemiology of fungal infections in China |
| Q40066669 | Epidemiology, risk factor, species distribution, antifungal resistance and outcome of Candidemia at a single French hospital: a 7-year study. |
| Q35973408 | Epidemiology, risk factors and outcome of Candida parapsilosis bloodstream infection in children |
| Q35977947 | Epidemiology, risk factors and therapy of candidemia in pediatric hematological patients |
| Q92504604 | Epidemiology, species distribution, antifungal susceptibility and mortality risk factors of candidemia among critically ill patients: a retrospective study from 2011 to 2017 in a teaching hospital in China |
| Q28740362 | Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy |
| Q37336194 | Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain |
| Q93088703 | Evaluation of Candida peritonitis with underlying peritoneal fibrosis and efficacy of micafungin in murine models of intra-abdominal candidiasis |
| Q28834232 | Evaluation of Fluorescent Capillary Electrophoresis for Rapid Identification of Candida Fungal Infections |
| Q91681606 | Evaluation of anidulafungin in the treatment of intra-abdominal candidiasis: a pooled analysis of patient-level data from 5 prospective studies |
| Q42222622 | Evaluation of antifungal use in a tertiary care institution: antifungal stewardship urgently needed |
| Q37582319 | Exacerbation of invasive Candida albicans infection by commensal bacteria or a glycolipid through IFN-γ produced in part by iNKT cells. |
| Q36953947 | Exploring ecological modelling to investigate factors governing the colonization success in nosocomial environment of Candida albicans and other pathogenic yeasts |
| Q92619791 | Febrile Neutropenia in Acute Leukemia. Epidemiology, Etiology, Pathophysiology and Treatment |
| Q35799819 | Fibronectin-, vitronectin- and laminin-binding proteins at the cell walls of Candida parapsilosis and Candida tropicalis pathogenic yeasts |
| Q43159219 | Five-year evaluation of bloodstream yeast infections in a tertiary hospital: the predominance of non-C. albicans Candida species. |
| Q39092120 | Fluconazole resistance in Candida species: a current perspective |
| Q36675142 | Fluconazole versus an echinocandin for Candida glabrata fungaemia: a retrospective cohort study |
| Q44919501 | Fluconazole-resistant Candida: collateral damage associated with prior antibacterial exposure? |
| Q52328152 | Functional diversification accompanies gene family expansion of MED2 homologs in Candida albicans. |
| Q55318324 | Functions of CD1d-Restricted Invariant Natural Killer T Cells in Antimicrobial Immunity and Potential Applications for Infection Control. |
| Q26741111 | Fungal Infection in the Brain: What We Learned from Intravital Imaging |
| Q38202571 | Fungal infections in cancer patients |
| Q37058527 | Fungal infections in intensive care unit: challenges in diagnosis and management |
| Q33896940 | Fungal infections in transplant and oncology patients |
| Q31119810 | Fungemia due to rare opportunistic yeasts: data from a population-based surveillance in Spain |
| Q28486002 | Genetic and genomic architecture of the evolution of resistance to antifungal drug combinations |
| Q35140108 | Genetic diversity among Korean Candida albicans bloodstream isolates: assessment by multilocus sequence typing and restriction endonuclease analysis of genomic DNA by use of BssHII. |
| Q40221882 | Genotyping of clinical isolates of Candida glabrata from Iran by multilocus sequence typing and determination of population structure and drug resistance profile |
| Q90086575 | Guidelines for Antibiotic Prescription in Intensive Care Unit |
| Q28533240 | Gymnemic acids inhibit hyphal growth and virulence in Candida albicans |
| Q40869564 | Heterogeneous expression of the virulence-related adhesin Epa1 between individual cells and strains of the pathogen Candida glabrata |
| Q33983074 | Horizontal transmission of Candida albicans and evidence of a vaccine response in mice colonized with the fungus |
| Q27028066 | Host response to Candida albicans bloodstream infection and sepsis |
| Q35568846 | How to treat fungal infections in ICU patients |
| Q40104195 | Hsf1 and Hsp90 orchestrate temperature-dependent global transcriptional remodelling and chromatin architecture in Candida albicans. |
| Q38179499 | Hsp90-dependent regulatory circuitry controlling temperature-dependent fungal development and virulence. |
| Q89986135 | Human inborn errors of immunity underlying superficial or invasive candidiasis |
| Q92320469 | IL-23 supports host defense against systemic Candida albicans infection by ensuring myeloid cell survival |
| Q37569167 | Identification of Candida Species Isolated from Renal Transplant Recipients with Candiduria |
| Q27335258 | Identification of Candida glabrata genes involved in pH modulation and modification of the phagosomal environment in macrophages |
| Q38590007 | Immune defence against Candida fungal infections |
| Q39040931 | Immune evasion, stress resistance, and efficient nutrient acquisition are crucial for intracellular survival of Candida glabrata within macrophages |
| Q90582415 | Impact of select risk factors on treatment outcome in adults with candidemia |
| Q49598880 | In Vivo Pharmacokinetics and Pharmacodynamics of APX001 against Candida spp. in a Neutropenic Disseminated Candidiasis Mouse Model. |
| Q53641731 | In vitro activity of Caspofungin combined with Fluconazole on mixed Candida albicans and Candida glabrata biofilm. |
| Q40609825 | In vitro antifungal activity of different components of Centratherum anthelminticum and Ocimum sanctum seed oils and their synergism against oral pathogenic fungi |
| Q41355300 | In vitro inhibitory activities of magnolol against Candida spp. |
| Q36414000 | In vitro susceptibilities of yeast species to fluconazole and voriconazole as determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study |
| Q34591430 | Incidence and clinical predictors of ocular candidiasis in patients with Candida fungemia. |
| Q41986535 | Increasing candidemia incidence from 2004 to 2015 with a shift in epidemiology in patients pre-exposed to antifungals |
| Q50097764 | Independent risk factors for mortality in critically ill patients with candidemia on Italian Internal Medicine Wards |
| Q34993661 | Infections in liver transplant recipients. |
| Q40449192 | Integrin Cross-Talk Regulates the Human Neutrophil Response to Fungal β-Glucan in the Context of the Extracellular Matrix: A Prominent Role for VLA3 in the Antifungal Response. |
| Q35131761 | Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series |
| Q26798127 | Interleukin 17-Mediated Host Defense against Candida albicans |
| Q34724039 | Intravenous anidulafungin followed optionally by oral voriconazole for the treatment of candidemia in Asian patients: results from an open-label Phase III trial |
| Q41654518 | Invasive Candida infections in patients of a medical intensive care unit: attempt of improving diagnosis by quantifying the colonization |
| Q42119440 | Invasive Candida infections in patients with haematological malignancies and hematopoietic stem cell transplant recipients: current epidemiology and therapeutic options |
| Q33851196 | Invasive Candidiasis due to Candida Norvegensis in a Liver Transplant Patient: Case Report and Literature Review |
| Q53697489 | Invasive Candidiasis in Critically Ill Patients: A Prospective Cohort Study in Two Tertiary Care Centers. |
| Q41189447 | Invasive Fungal Infections After Kidney Transplantation: A Single-center Experience. |
| Q36237993 | Invasive candidiasis in Pakistan: clinical characteristics, species distribution and antifungal susceptibility. |
| Q44732207 | Invasive candidiasis in intensive care units in China: a multicentre prospective observational study |
| Q35010671 | Invasive candidiasis in non-hematological patients |
| Q51172313 | Invasive fungal infections following liver transplantation: incidence, risk factors, survival, and impact of fluconazole-resistant Candida parapsilosis (2003-2007). |
| Q37373771 | Invasive fungal infections in patients with cancer in the Intensive Care Unit |
| Q38180287 | Invasive fungal infections in the ICU: how to approach, how to treat. |
| Q36267078 | Invasive infections due to Saprochaete and Geotrichum species: Report of 23 cases from the FungiScope Registry |
| Q29994504 | Investigating Clinical Issues by Genotyping of Medically Important Fungi: Why and How? |
| Q36959462 | Investigation of an unrecognized large-scale outbreak of Candida parapsilosis sensu stricto fungaemia in a tertiary-care hospital in China |
| Q35307936 | Investigation of minor species Candida africana, Candida stellatoidea and Candida dubliniensis in the Candida albicans complex among Yaoundé (Cameroon) HIV-infected patients |
| Q38535647 | Is Fluconazole or an Echinocandin the Agent of Choice for Candidemia. |
| Q37481878 | Is incidental recovery of yeast from enteric pathogen stool cultures obtained from hospitalized patients clinically significant? |
| Q41613426 | Isolation and drug susceptibility of Candida parapsilosis sensu lato and other species of C. parapsilosis complex from patients with blood stream infections and proposal of a novel LAMP identification method for the species. |
| Q40604477 | Lipopeptides from Bacillus subtilis AC7 inhibit adhesion and biofilm formation of Candida albicans on silicone |
| Q37612914 | Low Caspofungin Exposure in Patients in Intensive Care Units. |
| Q30827282 | MRI of CNS fungal infections: review of aspergillosis to histoplasmosis and everything in between |
| Q40621098 | Management of Candida guilliermondii joint infection in a dog. |
| Q42376003 | Mechanisms involved in the triggering of neutrophil extracellular traps (NETs) by Candida glabrata during planktonic and biofilm growth |
| Q31036601 | Mechanisms of Candida albicans trafficking to the brain |
| Q51361058 | Meeting the challenge of invasive fungal infections: part 2. |
| Q33913945 | MiR-146a negatively regulates dectin-1-induced inflammatory responses |
| Q37280669 | Microdilution in vitro Antifungal Susceptibility Patterns of Candida Species, From Mild Cutaneous to Bloodstream Infections. |
| Q35127111 | Milestones in Candida albicans gene manipulation |
| Q47877472 | Minimum inhibitory concentrations of amphotericin B against Candida krusei isolates from a French teaching hospital laboratory: a retrospective study over 8 years. |
| Q34189952 | Modulation of morphogenesis in Candida albicans by various small molecules |
| Q40902502 | Molecular Diversity of Candida albicans Isolated from Immunocompromised Patients, Based on MLST Method |
| Q55032135 | Molecular detection of fungal pathogens in clinical specimens by 18S rDNA high-throughput screening in comparison to ITS PCR and culture. |
| Q33615436 | Molecular evidence on the occurrence of co-infection with Pichia guilliermondii and Wuchereria bancrofti in two filarial endemic districts of India |
| Q38120763 | Molecular fingerprints to identify Candida species. |
| Q42043407 | Molecular identification of closely related Candida species using two ribosomal intergenic spacer fingerprinting methods |
| Q91589843 | Moonlighting proteins are variably exposed at the cell surfaces of Candida glabrata, Candida parapsilosis and Candida tropicalis under certain growth conditions |
| Q36675138 | Mortality in patients with early- or late-onset candidaemia |
| Q42133634 | Multilocus microsatellite markers for molecular typing of Candida glabrata: application to analysis of genetic relationships between bloodstream and digestive system isolates |
| Q36506445 | Multilocus sequence typing of Candida tropicalis shows the presence of different clonal clusters and fluconazole susceptibility profiles in sequential isolates from candidemia patients in Sao Paulo, Brazil |
| Q39112946 | Nebulized Liposomal Amphotericin B for Treatment of Pulmonary Infection Caused by Hormographiella aspergillata: Case Report and Literature Review. |
| Q37372151 | Neonatal fungal sepsis by Candida krusei: A report of three cases and a literature review |
| Q38202573 | Neutropenic fever and sepsis: evaluation and management |
| Q27002519 | New insights into innate immune control of systemic candidiasis |
| Q37782235 | New nonculture-based methods for the diagnosis of invasive candidiasis |
| Q40748882 | Nosocomial Bloodstream Infection Due to Candida spp. in China: Species Distribution, Clinical Features, and Outcomes |
| Q39195633 | Nosocomial candidemia in patients admitted to medicine wards compared to other wards: a multicentre study. |
| Q36112280 | Novel nanoscale bacteriophage-based single-domain antibodies for the therapy of systemic infection caused by Candida albicans |
| Q38061190 | Occurrence, presentation and treatment of candidemia |
| Q38363105 | Opportunistic yeast pathogens: reservoirs, virulence mechanisms, and therapeutic strategies |
| Q33851272 | Oropharyngeal candidiasis in children with lymphohematopoietic malignancies in Mashhad, Iran |
| Q35756098 | Overexpression of Both ERG11 and ABC2 Genes Might Be Responsible for Itraconazole Resistance in Clinical Isolates of Candida krusei |
| Q34596714 | PCR diagnosis of invasive candidiasis: systematic review and meta-analysis |
| Q34421006 | Performance comparison of phenotypic and molecular methods for detection and differentiation of Candida albicans and Candida dubliniensis |
| Q42263057 | Peripheral and total parenteral nutrition as the strongest risk factors for nosocomial candidemia in elderly patients: a matched case-control study |
| Q35105763 | Pharmacodynamic target evaluation of a novel oral glucan synthase inhibitor, SCY-078 (MK-3118), using an in vivo murine invasive candidiasis model |
| Q35270758 | Pharmacodynamics of echinocandins against Candida glabrata: requirement for dosage escalation to achieve maximal antifungal activity in neutropenic hosts |
| Q46248423 | Pharmacodynamics of the Long Acting Echinocandin, CD101, in the Neutropenic Invasive Candidiasis Murine Model Using an Extended Interval Dosing Design |
| Q64114656 | Pixel: a content management platform for quantitative omics data |
| Q40436784 | Polyclonal anti-Candida antibody improves phagocytosis and overall outcome in zebrafish model of disseminated candidiasis. |
| Q92284845 | Polymerase Chain Reaction Versus Blood Culture to Detect Candida Species in High-Risk Patients with Suspected Invasive Candidiasis: The MICAFEM Study |
| Q46163896 | Possible mechanism of antifungal phenazine-1-carboxamide from Pseudomonas sp. against dimorphic fungi Benjaminiella poitrasii and human pathogen Candida albicans. |
| Q46573245 | Pravastatin inhibits farnesol production in Candida albicans and improves survival in a mouse model of systemic candidiasis |
| Q28821330 | Preclinical Evaluation of the Stability, Safety, and Efficacy of CD101, a Novel Echinocandin |
| Q38883793 | Predisposing factors and outcome of uncommon yeast species-related fungaemia based on an exhaustive surveillance programme (2002-14). |
| Q89347255 | Prevalence of candidemia and associated candida subtypes following severe sepsis in non-neutropenic critically ill patients |
| Q42569335 | Primary Candida guilliermondii Infection of the Knee in a Patient without Predisposing Factors |
| Q37467192 | Prognostic factors for mortality with fungal blood stream infections in patients with hematological and non-hematological malignancies. |
| Q27681900 | Propargyl-Linked Antifolates are Dual Inhibitors of Candida albicans and Candida glabrata |
| Q27311102 | Protection of Candida parapsilosis from neutrophil killing through internalization by human endothelial cells |
| Q51174662 | Pyrosequencing of a hypervariable region in the internal transcribed spacer 2 to identify clinical yeast isolates. |
| Q38533738 | Quantification and optimization of Candida albicans DNA in blood samples using Real- Time PCR. |
| Q35139758 | Quantitation of Candida CFU in initial positive blood cultures |
| Q28543415 | Rapid identification of medically important Candida isolates using high resolution melting analysis |
| Q84965439 | Rapid identification of yeasts from positive blood culture bottles by pyrosequencing |
| Q34529026 | Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients |
| Q38131290 | Recent insights into Candida albicans biofilm resistance mechanisms |
| Q37682919 | Recently tested strategies to reduce nosocomial infections in the neonatal intensive care unit |
| Q39858508 | Reduced Oxidative Burst by Primed Neutrophils in the Elderly Individuals Is Associated With Increased Levels of the CD16bright/CD62Ldim Immunosuppressive Subset |
| Q54253525 | Reemergence of Intravenous Drug Use as Risk Factor for Candidemia, Massachusetts, USA. |
| Q28087413 | Regulatory roles of phosphorylation in model and pathogenic fungi |
| Q34528342 | Relationship of fluconazole prophylaxis with fungal microbiology in hospitalized intra-abdominal surgery patients: a descriptive cohort study |
| Q35310976 | Renal allograft pyelonephritis and fungemia due to Candida krusei |
| Q47107191 | Requirement for Ergosterol in Berberine Tolerance Underlies Synergism of Fluconazole and Berberine against Fluconazole-Resistant Candida albicans Isolates |
| Q36077230 | Resistance Surveillance in Candida albicans: A Five-Year Antifungal Susceptibility Evaluation in a Brazilian University Hospital. |
| Q34276700 | Resistance to antifungals that target CYP51. |
| Q40566844 | Risk factors for candidaemia in critically ill patients in intensive care units as compared to internal medicine wards |
| Q90714231 | Risk factors predicting Candida infective endocarditis in patients with candidemia |
| Q46556923 | Role of Aif1 in regulation of cell death under environmental stress in Candida albicans |
| Q34392438 | Role of endothelial cell septin 7 in the endocytosis of Candida albicans |
| Q49598032 | Role of the inducible adhesin, CpAls7, in binding of Candida parapsilosis to extracellular matrix under fluid shear |
| Q26747318 | Roles of IL-33 in Resistance and Tolerance to Systemic Candida albicans Infections |
| Q34643153 | Saccharomyces cerevisiae biofilm tolerance towards systemic antifungals depends on growth phase |
| Q34332272 | Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007 |
| Q34259665 | Self-adjuvanting glycopeptide conjugate vaccine against disseminated candidiasis |
| Q42118113 | Set of classical PCRs for detection of mutations in Candida glabrata FKS genes linked with echinocandin resistance |
| Q35108316 | Silenced suppressor of cytokine signaling 1 (SOCS1) enhances the maturation and antifungal immunity of dendritic cells in response to Candida albicans in vitro |
| Q36062751 | Similar efficacy of broad-range ITS PCR and conventional fungal culture for diagnosing fungal infections in non-immunocompromised patients. |
| Q43427231 | Six-year trend analysis of nosocomial candidemia and risk factors in two intensive care hospitals in Mato Grosso, midwest region of Brazil |
| Q28817906 | Structure-Activity Relationships of a Series of Echinocandins and the Discovery of CD101, a Highly Stable and Soluble Echinocandin with Distinctive Pharmacokinetic Properties |
| Q33618418 | Surveillance of Candida spp bloodstream infections: epidemiological trends and risk factors of death in two Mexican tertiary care hospitals |
| Q54247940 | Survival in Patients with Candida glabrata Bloodstream Infections is Associated with Fluconazole Dose. |
| Q35208352 | Syk signaling in dendritic cells orchestrates innate resistance to systemic fungal infection. |
| Q35105804 | Synergistic activity of chloroquine with fluconazole against fluconazole-resistant isolates of Candida species |
| Q35625551 | Synergistic antifungal activity of berberine derivative B-7b and fluconazole |
| Q28541182 | Synergistic antifungal effect of glabridin and fluconazole |
| Q39767106 | Synergistic effects of amiodarone and fluconazole on Candida tropicalis resistant to fluconazole. |
| Q41546170 | T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial |
| Q38178257 | Ten-year review of candidemia in a Canadian tertiary care centre: Predominance of non-albicans Candida species |
| Q84597136 | Ten-year study of species distribution and antifungal susceptibilities of Candida bloodstream isolates at a Brazilian tertiary hospital |
| Q91726605 | The Evolution of Azole Resistance in Candida albicans Sterol 14α-Demethylase (CYP51) through Incremental Amino Acid Substitutions |
| Q54242110 | The Frequency of Infective Endocarditis in Candida Bloodstream Infections: a Retrospective Study in a Child Hospital. |
| Q58725917 | The Genome of the Human Pathogen Is Shaped by Mutation and Cryptic Sexual Recombination |
| Q37632406 | The Prospective Antifungal Therapy Alliance(®) registry: A two-centre Canadian experience |
| Q37700546 | The current role of the reference procedures by CLSI and EUCAST in the detection of resistance to antifungal agents in vitro |
| Q33887429 | The effect of cumulative length of hospital stay on the antifungal resistance of Candida strains isolated from critically ill surgical patients |
| Q34335391 | The epidemiological profile of candidemia at an Indian trauma care center |
| Q39375216 | The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). |
| Q34586566 | The epidemiology, antifungal use and risk factors of death in elderly patients with candidemia: a multicentre retrospective study |
| Q30501710 | The interaction between Candida krusei and murine macrophages results in multiple outcomes, including intracellular survival and escape from killing |
| Q36516675 | The non-Geldanamycin Hsp90 inhibitors enhanced the antifungal activity of fluconazole |
| Q27026751 | The potential impact of antifungal drug resistance mechanisms on the host immune response to Candida |
| Q37742252 | The risk and clinical outcome of candidemia depending on underlying malignancy |
| Q53637746 | The usefulness of DNA sequencing after extraction by Whatman FTA filter matrix technology and phenotypic tests for differentiation of Candida albicans and Candida dubliniensis. |
| Q39468085 | Toll-like receptor 9 modulates macrophage antifungal effector function during innate recognition of Candida albicans and Saccharomyces cerevisiae. |
| Q33695068 | Transcriptional Responses of Candida albicans to Antimicrobial Peptide MAF-1A |
| Q36804662 | Transcriptional profiling of Candida glabrata during phagocytosis by neutrophils and in the infected mouse spleen |
| Q38125931 | Treatment and outcomes of Candida osteomyelitis: review of 53 cases from the PATH Alliance® registry. |
| Q35959489 | Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin:review of the literature |
| Q46752133 | Treatment of invasive candidiasis: between guidelines and daily clinical practice |
| Q36521993 | Triazole use in the nursery: fluconazole, voriconazole, posaconazole, and ravuconazole |
| Q35271053 | Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis |
| Q58786237 | Validation of a simplex PCR assay enabling reliable identification of clinically relevant Candida species |
| Q57034390 | Variability in antifungal utilization among neonatal, pediatric, and adult inpatients in academic medical centers throughout the United States of America |
| Q37374850 | Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007. |
| Q89983562 | Virulence assessment of six major pathogenic Candida species in the mouse model of invasive candidiasis caused by fungal translocation |
| Q34100598 | Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002-2010) |
| Q42624195 | Ydj1 governs fungal morphogenesis and stress response, and facilitates mitochondrial protein import via Mas1 and Mas2. |
| Q90424700 | Yeast and Filaments Have Specialized, Independent Activities in a Zebrafish Model of Candida albicans Infection |
Search more.